Today, Biosyent Inc shares opened at $8.60 and closed at $8.58. It traded at a low of $8.57 to a high of $8.60.

The price shrank -0.23 percent from the previous day's close of $8.60.

During the day across North America, the TSX Composite closed 0.46% at 22361.78, the S&P 500 closed 0.14% at 5209.91, the Dow Jones Industrial Average closed -0.02% at 38883.67 and the Nasdaq Composite closed 0.32% at 16306.64.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

A total of 5,900 shares was traded during the last trading day, with total trades of 9, with an average volume of 12,249 in the last five days.

Trading across the entire TSX-V saw 976 price advancers against 4,291 declines and 93 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have advanced 12.89% in the last 12 months, while this year, they have decreased -6.94%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $99.90 million on a float of 11,616 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc's consensus rating is "Moderate Buy" based on 1 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..